{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:13:53Z","timestamp":1790741633224,"version":"4.1.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,7,4]],"date-time":"2018-07-04T00:00:00Z","timestamp":1530662400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81100947"],"award-info":[{"award-number":["81100947"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biosci"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13578-018-0239-x","type":"journal-article","created":{"date-parts":[[2018,7,4]],"date-time":"2018-07-04T09:36:21Z","timestamp":1530696981000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Mutant huntingtin induces iron overload via up-regulating IRP1 in Huntington\u2019s disease"],"prefix":"10.1186","volume":"8","author":[{"given":"Li","family":"Niu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuifang","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiming","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weixi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,4]]},"reference":[{"key":"239_CR1","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"The Huntington\u2019s Disease Collaborative Research Group","year":"1993","unstructured":"The Huntington\u2019s Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. Cell. 1993;72:971\u201383.","journal-title":"Cell"},{"key":"239_CR2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S1474-4422(10)70276-3","volume":"10","author":"SJ Tabrizi","year":"2011","unstructured":"Tabrizi SJ, Scahill RI, Durr A, Roos RA, Leavitt BR, Jones R, et al. Biological and clinical changes in premanifest and early stage Huntington\u2019s disease in the TRACK-HD study: the 12-month longitudinal analysis. Lancet Neurol. 2011;10:31\u201342.","journal-title":"Lancet Neurol."},{"key":"239_CR3","doi-asserted-by":"publisher","first-page":"e41152","DOI":"10.1371\/journal.pone.0041152","volume":"7","author":"M Hogel","year":"2012","unstructured":"Hogel M, Laprairie RB, Denovan-Wright EM. Promoters are differentially sensitive to N-terminal mutant huntingtin-mediated transcriptional repression. PLoS ONE. 2012;7:e41152.","journal-title":"PLoS ONE"},{"key":"239_CR4","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1093\/hmg\/ddl481","volume":"16","author":"MC Chiang","year":"2007","unstructured":"Chiang MC, Chen HM, Lee YH, Chang HH, Wu YC, Soong BW, et al. Dysregulation of C\/EBPalpha by mutant Huntingtin causes the urea cycle deficiency in Huntington\u2019s disease. Hum Mol Genet. 2007;16:483\u201398.","journal-title":"Hum Mol Genet"},{"key":"239_CR5","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/emboj.2008.23","volume":"27","author":"T Yamanaka","year":"2008","unstructured":"Yamanaka T, Miyazaki H, Oyama F, Kurosawa M, Washizu C, Doi H, et al. Mutant Huntingtin reduces HSP70 expression through the sequestration of NF-Y transcription factor. EMBO J. 2008;27:827\u201339.","journal-title":"EMBO J."},{"key":"239_CR6","doi-asserted-by":"publisher","first-page":"9751","DOI":"10.1073\/pnas.1511810112","volume":"112","author":"I Ahmed","year":"2015","unstructured":"Ahmed I, Sbodio JI, Harraz MM, Tyagi R, Grima JC, Albacarys LK, et al. Huntington\u2019s disease: neural dysfunction linked to inositol polyphosphate multikinase. Proc Natl Acad Sci USA. 2015;112:9751\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"239_CR7","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nature13136","volume":"509","author":"BD Paul","year":"2014","unstructured":"Paul BD, Sbodio JI, Xu R, Vandiver MS, Cha JY, Snowman AM, et al. Cystathionine gamma-lyase deficiency mediates neurodegeneration in Huntington\u2019s disease. Nature. 2014;509:96\u2013100.","journal-title":"Nature"},{"key":"239_CR8","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.freeradbiomed.2016.06.023","volume":"100","author":"JC Corona","year":"2016","unstructured":"Corona JC, Duchen MR. PPARgamma as a therapeutic target to rescue mitochondrial function in neurological disease. Free Radic Biol Med. 2016;100:153\u201363.","journal-title":"Free Radic Biol Med."},{"key":"239_CR9","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.molmed.2009.01.001","volume":"15","author":"I Bezprozvanny","year":"2009","unstructured":"Bezprozvanny I. Calcium signaling and neurodegenerative diseases. Trends Mol Med. 2009;15:89\u2013100.","journal-title":"Trends Mol Med."},{"key":"239_CR10","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3233\/JHD-150182","volume":"5","author":"KL Berggren","year":"2016","unstructured":"Berggren KL, Lu Z, Fox JA, Dudenhoeffer M, Agrawal S, Fox JH. Neonatal iron supplementation induces striatal atrophy in female YAC128 Huntington\u2019s disease mice. J Huntingtons Dis. 2016;5:53\u201363.","journal-title":"J Huntingtons Dis."},{"key":"239_CR11","doi-asserted-by":"publisher","first-page":"789","DOI":"10.3174\/ajnr.A4617","volume":"37","author":"JM Bergen van","year":"2016","unstructured":"van Bergen JM, Hua J, Unschuld PG, Lim IA, Jones CK, Margolis RL, et al. Quantitative susceptibility mapping suggests altered brain iron in Premanifest Huntington disease. Am J Neuroradiol (AJNR). 2016;37:789\u201396.","journal-title":"Am J Neuroradiol (AJNR)"},{"key":"239_CR12","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.redox.2015.02.002","volume":"4","author":"KL Berggren","year":"2015","unstructured":"Berggren KL, Chen J, Fox J, Miller J, Dodds L, Dugas B, et al. Neonatal iron supplementation potentiates oxidative stress, energetic dysfunction and neurodegeneration in the R6\/2 mouse model of Huntington\u2019s disease. Redox Biol. 2015;4:363\u201374.","journal-title":"Redox Biol."},{"key":"239_CR13","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1038\/npp.2011.22","volume":"36","author":"G Bartzokis","year":"2011","unstructured":"Bartzokis G, Lu PH, Tingus K, Peters DG, Amar CP, Tishler TA, et al. Gender and iron genes may modify associations between brain iron and memory in healthy aging. Neuropsychopharmacology. 2011;36:1375\u201384.","journal-title":"Neuropsychopharmacology."},{"key":"239_CR14","doi-asserted-by":"publisher","first-page":"e77023","DOI":"10.1371\/journal.pone.0077023","volume":"8","author":"J Chen","year":"2013","unstructured":"Chen J, Marks E, Lai B, Zhang Z, Duce JA, Lam LQ, et al. Iron accumulates in Huntington\u2019s disease neurons: protection by deferoxamine. PLoS ONE. 2013;8:e77023.","journal-title":"PLoS ONE"},{"key":"239_CR15","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.neuroimage.2012.03.056","volume":"61","author":"EM Dumas","year":"2012","unstructured":"Dumas EM, Versluis MJ, van den Bogaard SJ, van Osch MJ, Hart EP, van Roon-Mom WM, et al. Elevated brain iron is independent from atrophy in Huntington\u2019s disease. Neuroimage. 2012;61:558\u201364.","journal-title":"Neuroimage."},{"key":"239_CR16","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1001\/archneurol.2011.2945","volume":"69","author":"HD Rosas","year":"2012","unstructured":"Rosas HD, Chen YI, Doros G, Salat DH, Chen NK, Kwong KK, et al. Alterations in brain transition metals in Huntington disease: an evolving and intricate story. Arch Neurol. 2012;69:887\u201393.","journal-title":"Arch Neurol"},{"key":"239_CR17","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1111\/jnc.12739","volume":"130","author":"M Muller","year":"2014","unstructured":"Muller M, Leavitt BR. Iron dysregulation in Huntington\u2019s disease. J Neurochem. 2014;130:328\u201350.","journal-title":"J Neurochem"},{"key":"239_CR18","doi-asserted-by":"publisher","first-page":"5428","DOI":"10.1111\/j.1742-4658.2006.05537.x","volume":"273","author":"WJ Firdaus","year":"2006","unstructured":"Firdaus WJ, Wyttenbach A, Giuliano P, Kretz-Remy C, Currie RW, Arrigo AP. Huntingtin inclusion bodies are iron-dependent centers of oxidative events. FEBS J. 2006;273:5428\u201341.","journal-title":"FEBS J"},{"key":"239_CR19","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/bs.mie.2017.09.006","volume":"599","author":"GP Holmes-Hampton","year":"2018","unstructured":"Holmes-Hampton GP, Ghosh MC, Rouault TA. Methods for studying iron regulatory protein 1: an important protein in human iron metabolism. Methods Enzymol. 2018;599:139\u201355.","journal-title":"Methods Enzymol"},{"key":"239_CR20","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1074\/jbc.M112.426171","volume":"288","author":"JC Ruiz","year":"2013","unstructured":"Ruiz JC, Walker SD, Anderson SA, Eisenstein RS, Bruick RK. F-box and leucine-rich repeat protein 5 (FBXL5) is required for maintenance of cellular and systemic iron homeostasis. J Biol Chem. 2013;288:552\u201360.","journal-title":"J Biol Chem"},{"key":"239_CR21","doi-asserted-by":"publisher","first-page":"15451","DOI":"10.1074\/jbc.270.26.15451","volume":"270","author":"PA DeRusso","year":"1995","unstructured":"DeRusso PA, Philpott CC, Iwai K, Mostowski HS, Klausner RD, Rouault TA. Expression of a constitutive mutant of iron regulatory protein 1 abolishes iron homeostasis in mammalian cells. J Biol Chem. 1995;270:15451\u20134.","journal-title":"J Biol Chem"},{"key":"239_CR22","doi-asserted-by":"publisher","first-page":"21645","DOI":"10.1074\/jbc.270.37.21645","volume":"270","author":"B Guo","year":"1995","unstructured":"Guo B, Phillips JD, Yu Y, Leibold EA. Iron regulates the intracellular degradation of iron regulatory protein 2 by the proteasome. J Biol Chem. 1995;270:21645\u201351.","journal-title":"J Biol Chem"},{"key":"239_CR23","doi-asserted-by":"publisher","first-page":"3428","DOI":"10.1073\/pnas.1519473113","volume":"113","author":"P Matak","year":"2016","unstructured":"Matak P, Matak A, Moustafa S, Aryal DK, Benner EJ, Wetsel W, et al. Disrupted iron homeostasis causes dopaminergic neurodegeneration in mice. Proc Natl Acad Sci USA. 2016;113:3428\u201335.","journal-title":"Proc Natl Acad Sci USA"},{"key":"239_CR24","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1093\/hmg\/ddm138","volume":"16","author":"AL Lumsden","year":"2007","unstructured":"Lumsden AL, Henshall TL, Dayan S, Lardelli MT, Richards RI. Huntingtin-deficient zebrafish exhibit defects in iron utilization and development. Hum Mol Genet. 2007;16:1905\u201320.","journal-title":"Hum Mol Genet"},{"key":"239_CR25","doi-asserted-by":"publisher","first-page":"12784","DOI":"10.1073\/pnas.221451398","volume":"98","author":"YJ Kim","year":"2001","unstructured":"Kim YJ, Yi Y, Sapp E, Wang Y, Cuiffo B, Kegel KB, et al. Caspase 3-cleaved N-terminal fragments of wild-type and mutant huntingtin are present in normal and Huntington\u2019s disease brains, associate with membranes, and undergo calpain-dependent proteolysis. Proc Natl Acad Sci USA. 2001;98:12784\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"239_CR26","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1093\/hmg\/ddm217","volume":"16","author":"RS Atwal","year":"2007","unstructured":"Atwal RS, Xia J, Pinchev D, Taylor J, Epand RM, Truant R. Huntingtin has a membrane association signal that can modulate huntingtin aggregation, nuclear entry and toxicity. Hum Mol Genet. 2007;16:2600\u201315.","journal-title":"Hum Mol Genet"},{"key":"239_CR27","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1002\/jcb.25147","volume":"116","author":"CM Cheng","year":"2015","unstructured":"Cheng CM, Wang D, Cao X, Luo QQ, Lu YP, Zhu L. Iron regulatory protein 1 suppresses hypoxia-induced iron uptake proteins expression and decreases iron levels in HepG2 cells. J Cell Biochem. 2015;116:1919\u201331.","journal-title":"J Cell Biochem"},{"key":"239_CR28","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.cmet.2015.01.010","volume":"21","author":"A Martelli","year":"2015","unstructured":"Martelli A, Schmucker S, Reutenauer L, Mathieu JRR, Peyssonnaux C, Karim Z, et al. Iron regulatory protein 1 sustains mitochondrial iron loading and function in frataxin deficiency. Cell Metab. 2015;21:311\u201323.","journal-title":"Cell Metab"},{"key":"239_CR29","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.neurobiolaging.2003.09.005","volume":"25","author":"G Bartzokis","year":"2004","unstructured":"Bartzokis G, Sultzer D, Lu PH, Nuechterlein KH, Mintz J, Cummings JL. Heterogeneous age-related breakdown of white matter structural integrity: implications for cortical \u201cdisconnection\u201d in aging and Alzheimer\u2019s disease. Neurobiol Aging. 2004;25:843\u201351.","journal-title":"Neurobiol Aging"},{"key":"239_CR30","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1148\/radiol.10100612","volume":"257","author":"S Haller","year":"2010","unstructured":"Haller S, Bartsch A, Nguyen D, Rodriguez C, Emch J, Gold G, et al. Cerebral microhemorrhage and iron deposition in mild cognitive impairment: susceptibility-weighted MR imaging assessment. Radiology. 2010;257:764\u201373.","journal-title":"Radiology"},{"key":"239_CR31","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.jns.2007.05.018","volume":"263","author":"J Vymazal","year":"2007","unstructured":"Vymazal J, Klempir J, Jech R, Zidovska J, Syka M, Ruzicka E, et al. MR relaxometry in Huntington\u2019s disease: correlation between imaging, genetic and clinical parameters. J Neurol Sci. 2007;263:20\u20135.","journal-title":"J Neurol Sci"},{"key":"239_CR32","doi-asserted-by":"publisher","first-page":"e11838","DOI":"10.1371\/journal.pone.0011838","volume":"5","author":"NG Innamorato","year":"2010","unstructured":"Innamorato NG, Jazwa A, Rojo AI, Garcia C, Fernandez-Ruiz J, Grochot-Przeczek A, et al. Different susceptibility to the Parkinson\u2019s toxin MPTP in mice lacking the redox master regulator Nrf2 or its target gene heme oxygenase-1. PLoS ONE. 2010;5:e11838.","journal-title":"PLoS ONE"},{"key":"239_CR33","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s00406-016-0707-4","volume":"266","author":"S Morkl","year":"2016","unstructured":"Morkl S, Muller NJ, Blesl C, Wilkinson L, Tmava A, Wurm W, et al. Problem solving, impulse control and planning in patients with early- and late-stage Huntington\u2019s disease. Eur Arch Psychiatry Clin Neurosci. 2016;266:663\u201371.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"239_CR34","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.jtemb.2014.11.009","volume":"30","author":"XH Dong","year":"2015","unstructured":"Dong XH, Gao WJ, Shao TM, Xie HL, Bai JT, Zhao JY, et al. Age-related changes of brain iron load changes in the frontal cortex in APPswe\/PS1DeltaE9 transgenic mouse model of Alzheimer\u2019s disease. J Trace Elem Med Biol. 2015;30:118\u201323.","journal-title":"J Trace Elem Med Biol"},{"key":"239_CR35","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1109\/TMI.2014.2358552","volume":"34","author":"CB Poynton","year":"2015","unstructured":"Poynton CB, Jenkinson M, Adalsteinsson E, Sullivan EV, Pfefferbaum A, Wells W 3rd. Quantitative susceptibility mapping by inversion of a perturbation field model: correlation with brain iron in normal aging. IEEE Trans Med Imaging. 2015;34:339\u201353.","journal-title":"IEEE Trans Med Imaging"},{"key":"239_CR36","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.freeradbiomed.2014.06.023","volume":"74","author":"M Ribeiro","year":"2014","unstructured":"Ribeiro M, Rosenstock TR, Oliveira AM, Oliveira CR, Rego AC. Insulin and IGF-1 improve mitochondrial function in a PI-3K\/Akt-dependent manner and reduce mitochondrial generation of reactive oxygen species in Huntington\u2019s disease knock-in striatal cells. Free Radic Biol Med. 2014;74:129\u201344.","journal-title":"Free Radic Biol Med."},{"key":"239_CR37","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1750-1326-8-45","volume":"8","author":"RA Quintanilla","year":"2013","unstructured":"Quintanilla RA, Jin YN, von Bernhardi R, Johnson GV. Mitochondrial permeability transition pore induces mitochondria injury in Huntington disease. Mol Neurodegener. 2013;8:45.","journal-title":"Mol Neurodegener."},{"key":"239_CR38","doi-asserted-by":"publisher","first-page":"11840","DOI":"10.1073\/pnas.0502177102","volume":"102","author":"T Nguyen","year":"2005","unstructured":"Nguyen T, Hamby A, Massa SM. Clioquinol down-regulates mutant huntingtin expression in vitro and mitigates pathology in a Huntington\u2019s disease mouse model. Proc Natl Acad Sci USA. 2005;102:11840\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"239_CR39","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13024-017-0218-4","volume":"12","author":"ZD Zhou","year":"2017","unstructured":"Zhou ZD, Tan EK. Iron regulatory protein (IRP)-iron responsive element (IRE) signaling pathway in human neurodegenerative diseases. Mol Neurodegener. 2017;12:75.","journal-title":"Mol Neurodegener."},{"key":"239_CR40","doi-asserted-by":"publisher","first-page":"130","DOI":"10.3390\/ijms17010130","volume":"17","author":"R Gozzelino","year":"2016","unstructured":"Gozzelino R, Arosio P. Iron homeostasis in health and disease. Int J Mol Sci. 2016;17:130.","journal-title":"Int J Mol Sci"},{"key":"239_CR41","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/nrn3453","volume":"14","author":"TA Rouault","year":"2013","unstructured":"Rouault TA. Iron metabolism in the CNS: implications for neurodegenerative diseases. Nat Rev Neurosci. 2013;14:551\u201364.","journal-title":"Nat Rev Neurosci"},{"key":"239_CR42","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1093\/hmg\/9.19.2799","volume":"9","author":"F Trettel","year":"2000","unstructured":"Trettel F, Rigamonti D, Hilditch-Maguire P, Wheeler VC, Sharp AH, Persichetti F, et al. Dominant phenotypes produced by the HD mutation in STHdh(Q111) striatal cells. Hum Mol Genet. 2000;9:2799\u2013809.","journal-title":"Hum Mol Genet"},{"key":"239_CR43","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/S0168-9525(01)02625-7","volume":"18","author":"DC Rubinsztein","year":"2002","unstructured":"Rubinsztein DC. Lessons from animal models of Huntington\u2019s disease. Trends Genet. 2002;18:202\u20139.","journal-title":"Trends Genet"},{"key":"239_CR44","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1111\/j.1471-4159.2005.03411.x","volume":"95","author":"BG Jenkins","year":"2005","unstructured":"Jenkins BG, Andreassen OA, Dedeoglu A, Leavitt B, Hayden M, Borchelt D, et al. Effects of CAG repeat length, HTT protein length and protein context on cerebral metabolism measured using magnetic resonance spectroscopy in transgenic mouse models of Huntington\u2019s disease. J Neurochem. 2005;95:553\u201362.","journal-title":"J Neurochem"},{"key":"239_CR45","doi-asserted-by":"publisher","first-page":"13589","DOI":"10.1523\/JNEUROSCI.4286-09.2009","volume":"29","author":"AL Southwell","year":"2009","unstructured":"Southwell AL, Ko J, Patterson PH. Intrabody gene therapy ameliorates motor, cognitive, and neuropathological symptoms in multiple mouse models of Huntington\u2019s disease. J Neurosci. 2009;29:13589\u2013602.","journal-title":"J Neurosci"},{"key":"239_CR46","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","volume":"87","author":"L Mangiarini","year":"1996","unstructured":"Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, Hetherington C, et al. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell. 1996;87:493\u2013506.","journal-title":"Cell"},{"key":"239_CR47","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1093\/hmg\/8.3.397","volume":"8","author":"G Schilling","year":"1999","unstructured":"Schilling G, Becher MW, Sharp AH, Jinnah HA, Duan K, Kotzuk JA, et al. Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin. Hum Mol Genet. 1999;8:397\u2013407.","journal-title":"Hum Mol Genet"},{"key":"239_CR48","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1006\/nbdi.2001.0406","volume":"8","author":"OA Andreassen","year":"2001","unstructured":"Andreassen OA, Dedeoglu A, Ferrante RJ, Jenkins BG, Ferrante KL, Thomas M, et al. Creatine increase survival and delays motor symptoms in a transgenic animal model of Huntington\u2019s disease. Neurobiol Dis. 2001;8:479\u201391.","journal-title":"Neurobiol Dis"},{"key":"239_CR49","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3389\/fnagi.2013.00034","volume":"5","author":"D Hare","year":"2013","unstructured":"Hare D, Ayton S, Bush A, Lei P. A delicate balance: iron metabolism and diseases of the brain. Front Aging Neurosci. 2013;5:34.","journal-title":"Front Aging Neurosci."},{"key":"239_CR50","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1111\/j.1471-4159.2006.04023.x","volume":"98","author":"T Moos","year":"2006","unstructured":"Moos T, Skjoerringe T, Gosk S, Morgan EH. Brain capillary endothelial cells mediate iron transport into the brain by segregating iron from transferrin without the involvement of divalent metal transporter 1. J Neurochem. 2006;98:1946\u201358.","journal-title":"J Neurochem"},{"key":"239_CR51","doi-asserted-by":"publisher","first-page":"3723","DOI":"10.1073\/pnas.83.11.3723","volume":"83","author":"RL Idzerda","year":"1986","unstructured":"Idzerda RL, Huebers H, Finch CA, McKnight GS. Rat transferrin gene expression: tissue-specific regulation by iron deficiency. Proc Natl Acad Sci USA. 1986;83:3723\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"239_CR52","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1093\/nar\/23.12.2206","volume":"23","author":"BE Sawaya","year":"1995","unstructured":"Sawaya BE, Schaeffer E. Transcription of the human transferrin gene in neuronal cells. Nucleic Acids Res. 1995;23:2206\u201311.","journal-title":"Nucleic Acids Res"},{"key":"239_CR53","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.nbd.2008.05.005","volume":"31","author":"PA Desplats","year":"2008","unstructured":"Desplats PA, Lambert JR, Thomas EA. Functional roles for the striatal-enriched transcription factor, Bcl11b, in the control of striatal gene expression and transcriptional dysregulation in Huntington\u2019s disease. Neurobiol Dis. 2008;31:298\u2013308.","journal-title":"Neurobiol Dis"},{"key":"239_CR54","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/0024-3205(95)00055-B","volume":"56","author":"AC Bowling","year":"1995","unstructured":"Bowling AC, Beal MF. Bioenergetic and oxidative stress in neurodegenerative diseases. Life Sci. 1995;56:1151\u201371.","journal-title":"Life Sci"},{"key":"239_CR55","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1097\/WCO.0b013e328304b692","volume":"21","author":"E Roze","year":"2008","unstructured":"Roze E, Saudou F, Caboche J. Pathophysiology of Huntington\u2019s disease: from huntingtin functions to potential treatments. Curr Opin Neurol. 2008;21:497\u2013503.","journal-title":"Curr Opin Neurol"},{"key":"239_CR56","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1152\/physrev.00041.2009","volume":"90","author":"C Zuccato","year":"2010","unstructured":"Zuccato C, Valenza M, Cattaneo E. Molecular mechanisms and potential therapeutical targets in Huntington\u2019s disease. Physiol Rev. 2010;90:905\u201381.","journal-title":"Physiol Rev"},{"key":"239_CR57","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1002\/glia.20526","volume":"55","author":"DA Simmons","year":"2007","unstructured":"Simmons DA, Casale M, Alcon B, Pham N, Narayan N, Lynch G, et al. Ferritin accumulation in dystrophic microglia is an early event in the development of Huntington\u2019s disease. Glia. 2007;55:1074\u201384.","journal-title":"Glia."},{"key":"239_CR58","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1007\/s11064-007-9352-7","volume":"32","author":"G Bartzokis","year":"2007","unstructured":"Bartzokis G, Lu PH, Tishler TA, Fong SM, Oluwadara B, Finn JP, et al. Myelin breakdown and iron changes in Huntington\u2019s disease: pathogenesis and treatment implications. Neurochem Res. 2007;32:1655\u201364.","journal-title":"Neurochem Res"}],"container-title":["Cell &amp; Bioscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13578-018-0239-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13578-018-0239-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13578-018-0239-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T07:44:14Z","timestamp":1568965454000},"score":1,"resource":{"primary":{"URL":"https:\/\/cellandbioscience.biomedcentral.com\/articles\/10.1186\/s13578-018-0239-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,4]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["239"],"URL":"https:\/\/doi.org\/10.1186\/s13578-018-0239-x","relation":{},"ISSN":["2045-3701"],"issn-type":[{"value":"2045-3701","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,4]]},"assertion":[{"value":"9 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"41"}}